Literature DB >> 20347500

Surrogate endpoints and non-inferiority trials in chronic viral hepatitis.

Ivan Gentile, Guglielmo Borgia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20347500     DOI： 10.1016/j.jhep.2009.12.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study.

Authors:  Matteo Nicola Dario Di Minno; Pasquale Ambrosino; Antonio Riccardo Buonomo; Biagio Pinchera; Ilenia Calcaterra; Manuel Crispo; Riccardo Scotto; Francesco Borgia; Consalvo Mattia; Ivan Gentile
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

Review 2.  Cirrhosis and its complications: evidence based treatment.

Authors:  Salman Nusrat; Muhammad S Khan; Javid Fazili; Mohammad F Madhoun
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

3.  Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.

Authors:  Lars Haukali Omland; Peer Brehm Christensen; Henrik Krarup; Peter Jepsen; Nina Weis; Henrik Toft Sørensen; Niels Obel
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

Review 4.  Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.

Authors:  Ivan Gentile; Antonio Riccardo Buonomo; Emanuela Zappulo; Giuseppina Minei; Filomena Morisco; Francesco Borrelli; Nicola Coppola; Guglielmo Borgia
Journal:  Ther Clin Risk Manag       Date:  2014-06-26       Impact factor: 2.423

5.  Treatment of hepatitis C virus infection in the future.

Authors:  Tatsuo Kanda; Osamu Yokosuka; Masao Omata
Journal:  Clin Transl Med       Date:  2013-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.